ITIH4 and infection: Likewise, there was no evidence that the number of challenges to infection correlated with the infant plasma neutralization titer against MW965 (Fig. 8B) or the ADCC endpoint titer against 1086.C or SHIV1157ipd3N4 gp120-coated target cells (Fig. 8C).